Pregabalin Capsule 150 mg (Pregabalin)
Pregabalin 150mg
Hard capsule · Prescription medication
Sungwon Adcock Pharmaceutical Co., Ltd.
MFDS item code 201902107 · Approved 2019.04.05
This product's status changed to Expired on 2024.04.05. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Relief of peripheral and central neuropathic pain, adjunctive treatment for partial seizures, improvement of fibromyalgia.
This medication treats peripheral and central neuropathic pain in adults. It is also used as an adjunct in patients with epilepsy for partial seizures, showing effectiveness even in cases with secondary generalized symptoms. Additionally, it helps alleviate symptoms of fibromyalgia. In other words, it is used for various neurological-related disorders such as neuralgias, seizures, and fibromyalgia.
This medication, containing pregabalin, should be administered orally, divided into two doses per day regardless of food intake. 1. Neuropathic Pain 1) Peripheral Neuropathic Pain The starting dose is 150 mg per day, which can be increased to 300 mg per day after 3 to 7 days. If necessary, it can be further increased to a maximum of 600 mg per day at intervals of 7 days. 2) Central Neuropathic Pain The starting dose is 150 mg per day.
There is insufficient data on the safety and efficacy of this medication in pediatric patients under 12 years of age and adolescents aged 12 to 17, so administration is not recommended.
This medication may increase the risk of suicidal thoughts or behaviors, so it is essential to closely monitor for signs of depression, mood changes, or unusual behavior during treatment. There are contraindications for this medication: individuals allergic to this drug or its components or those with specific genetic conditions such as lactose intolerance should not take it. Diabetic patients may need to adjust their blood sugar control medications due to weight gain after taking this drug. If symptoms of allergic reactions, such as angioedema, appear, the medication should be discontinued immediately. Elderly patients should be cautious of the risk of falls or injuries due to dizziness or drowsiness when taking this medication, and they need to consult a physician if they experience blurred vision or changes in eyesight. Abruptly stopping this medication may cause withdrawal symptoms such as insomnia, headaches, nausea, and anxiety, so it should be tapered gradually according to a doctor's instructions. There is a risk of drug abuse or dependence, so patients with a history of mental illness should be monitored closely and checked for any signs of substance abuse. Patients with cardiovascular disease or kidney dysfunction should be cautious when taking this medication, and especially those with severe congestive heart failure should be administered carefully. Taking this medication with opioid pain relievers may increase central nervous system suppression, leading to a higher risk of respiratory depression, so caution is advised. In the early stages of pregnancy, there may be a risk of congenital malformations to the fetus, thus women who are pregnant or planning to become pregnant must consult their physician and employ effective contraceptive methods. Breastfeeding women should carefully consider the benefits and risks of taking this medication, as it may be transmitted through breast milk and affect the baby. It is safest to avoid activities requiring attention, such as driving or operating machinery, until dizziness or drowsiness fully resolves after taking this medication. In case of overdose, symptoms such as confusion, depression, drowsiness, and seizures may occur, and treatment such as hemodialysis may be required if necessary. This medication should be kept out of reach of children, and caution should be exercised as transferring it to a different container may alter its quality.
Hives, severe swelling (angioedema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with fever, blisters, skin peeling, pain in mouth/eye mucous membranes, shortness of breath or difficulty breathing, asthma attack, respiratory abnormalities with cough+fever, yellowing of skin or eyes (jaundice), extreme lethargy, sudden and severe headache, lightning-like headache, seizure, confusion of consciousness, visual disturbances, paralysis,
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent exposure to air or moisture, in a cool place between 15 to 30 degrees Celsius. Storing it this way will help maintain the medication's efficacy for a longer time.
A hard capsule with white powder inside, white in color.
30 capsules/bottle, 60 capsules/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Pregabalin 150mg
Hard capsule · Prescription medication
Sungwon Adcock Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 300mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Hanmi Pharm. Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Hanmi Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.